August 31, 2023: FDA’s Robert Califf and Coauthors Assert More Is Needed to Achieve Learning Health Care

A graphic that includes the cover image from the August 2023 issue of the American Journal of Bioethics. The text in the graphic reads as follows: "American Journal of Bioethics Special issue on pragmatic trials, featuring target articles from the NIH Pragmatic Trials Collaboratory."In an article published this month in the American Journal of Bioethics, FDA Commissioner Robert Califf and coauthors suggest that—despite the potential of embedded pragmatic research to generate information to improve clinical practice and public health policy—it is still relatively uncommon in US healthcare.

“Simply stated, what we are currently doing does not work, and in the face of declining health status we lack answers to critical questions about what we should be doing in health care and public health practice.”

The authors state 3 major obstacles:

  • Inadequate data systems: Electronic health records are not designed for research use, and are driven by billing codes and reimbursement structures.
  • Data sharing malaise: We have failed to develop a convincing paradigm for sharing individual-level data from routine healthcare delivery
  • Current oversight: Research oversight is still not designed to facilitate embedded pragmatic clinical trials or research using real-world evidence.

The authors suggest that achieving a learning health system will require

  • More collaboration between health systems and businesses involved in healthcare
  • More innovative structures for data sharing across institutions
  • Incentives for building the sophisticated infrastructure necessary to enable this work
  • Considerations from the bioethics community about how best to foster this research while respecting all those who participate

This article was part of a special issue of the American Journal of Bioethics on pragmatic clinical trials. Members of the Ethics and Regulatory Core contributed the target articles to this issue regarding investigator obligations and the clinician’s duty to participate in embedded research.

 

May 2, 2022: Califf Reflects on Origins and Impact of NIH Pragmatic Trials Collaboratory

In a keynote speech at the NIH Pragmatic Trials Collaboratory Steering Committee annual meeting, FDA Commissioner Dr. Rob Califf called for more and faster evidence generation. “We have to generate evidence more quickly and then insist that it gets used,” he said.

After his remarks, Califf joined Dr. Wendy Weber of the National Center for Complementary and Integrative Health to reflect on the origins and impact of the program. Califf was the first principal investigator of the program’s Coordinating Center, and Weber is the NIH program officer.

“We have a huge need for evidence, we have sources of data now that are digital and readily available,” Califf said. “So we should have consortia of investigators and patients who work together to get the answers as quickly as possible.

Califf noted that an important part of the original application for NIH funding was “a recognition that this was a startup and that it would be a work in progress.”

View the full interview.

Dr. Robert CaliffOn what has surprised him the most – “Patients and clinicians pretty readily grasp the need and the concept. They want to do it. The data part is a lot harder than most people thought. The technology has come a long way; we can do it now. Probably the hardest thing has actually been that the business models for health systems run counter to generating evidence. It’s something that we really haven’t overcome at this point.”

On opportunities for the program – “I think the program needs to keep the model that it has, but I’m hoping we can build in the incentive forces that are really needed to have it become, I will call it, ‘viral.’ We all want to know what the best treatment is, how to compare treatments, all the things that are involved in the network. Between FDA and NIH, and now CMS much more involved, and the interest of private industry, we could potentially really create the incentives that allow people to do what they now know how to do so well.”

On the legacy of the program – “I hope we’ll look back and say the Collaboratory and the things around the Collaboratory stimulated a new way of doing research that became the main way that we do research.”

See the complete materials from the 2022 Steering Committee meeting.

Dr. Califf to Speak Today at NIH Common Fund 10-Year Commemoration Symposium


On June 19, 2014, the NIH Common Fund is celebrating 10 years of achievement with a symposium, A Decade of Discovery, featuring its far-reaching research. Dr. Robert Califf, principal investigator of the NIH Collaboratory Coordinating Center, will speak during the 2:15-3:15 pm session “Reengineering the Clinical Research Enterprise.” Proceedings will be streamed live throughout the day.

View the agenda, live videocast, and commemorative book

Winners from the video and song contest will also be recognized.